| Product Name | MF | CAS | Details |
|---|
| Maraviroc-d6 | C29H41F2N5O | 1033699-22-7 | Details |
| 6,8-Difluoro-4-methylumbelliferyl b-D-cellotetraoside | Details |
| 1-(Pyrazin-2-yl)ethan-1-amine dihydrochloride | C6H10ClN3 | 2137775-24-5 | Details |
| GDP-L-fucose disodium salt | C16H26N5NaO15P2 | 148296-47-3 | Details |
| EGFR-derived peptide | Details |
| Dimethyl 3-aminopentanedioate hydrochloride | C7H14ClNO4 | 77313-10-1 | Details |
| (1,2,3,4-tetrahydroisoquinolin-6-yl)methanol hydrochloride | C10H14ClNO | 2152637-00-6 | Details |
| 3-(3-Chlorophenyl)-5-methyl-1,2-oxazole-4-carboxylic acid | C11H8ClNO3 | 92545-95-4 | Details |
| (R)-N,N-Dimethylpiperidin-3-amine dihydrochloride | C7H17ClN2 | 1152110-75-2 | Details |
| 3-(2-Chlorophenyl)cyclobutan-1-one | C10H9ClO | 1080636-35-6 | Details |
| 9,9'-o-Isopropyllidene-isolariciresinol | C23H28O6 | 252333-71-4 | Details |
| α,α-Dimethyl-4-[(methylamino)methyl]-2-thiazolemethanol hydrochloride | C8H14N2OS | 1051463-24-1 | Details |
| 5-(1-aza-2-(4-(dimethylamino)phenyl)vinyl)-4-imino-2-oxo-3-phenyl-1H-1,3-diazine-6-carbonitrile | C20H18N6O | 1159976-56-3 | Details |
| 5-(4-Ethoxyphenyl)-2H-1,2,3,4-tetrazole | C9H10N4O | 338426-38-3 | Details |
| 3-(4-Butylcyclohexyl)-3-oxopropanenitrile | C13H21NO | 1092306-03-0 | Details |
| Dr4004 hydrochloride | C26H31ClN2O | 201608-40-4 | Details |
| 2-(2-methyloxetan-2-yl)benzoate lithium | 2155852-03-0 | Details |
| Karacoline | C22H35NO4 | 39089-30-0 | Details |
| WNK3 Blocking Peptide | Details |
| 3-Desmethyl-3-(5-oxohexyl) pentoxifylline | C18H26N4O4 | 1329835-59-7 | Details |
| N-Des(2-diethylamino) metoclopramide acetic acid | C10H11ClN2O4 | 65567-29-5 | Details |
| 2-Methyl-3-nitroaniline | C7H8N2O2 | 603-83-8 | Details |
| rac-(3R,4R)-4-(Benzylamino)piperidin-3-ol dihydrochloride | C12H19ClN2O | 114870-73-4 | Details |
| Methyl 2-amino-5-cyclopropylthiophene-3-carboxylate | C9H11NO2S | 439692-97-4 | Details |
| 2-(1H-Indol-3-yl)-benzothiazole | C15H10N2S | 31224-76-7 | Details |
| Fmoc-Trp-Rink-Amide MBHA Resin | Details |
| 5-(Aminosulfonyl)-2-bromobenzoic acid | C7H6BrNO4S | 22361-61-1 | Details |
| 4-Oxo-2-phenyl-1,4-dihydroquinoline-3-carboxylic acid | C16H11NO3 | 13180-35-3 | Details |
| 5-(Benzyloxy)pyrazine-2-carboxylic acid | C12H10N2O3 | 1410093-53-6 | Details |
| FOP antibody | Details |
| 2-Methyl-2-(oxan-2-yl)propanoic acid | C9H16O3 | 1447943-52-3 | Details |
| Ethyl 4-amino-2,2-difluorobutanoate hydrochloride | C6H12ClF2NO2 | 2243512-15-2 | Details |
| 2-(4-Methylpiperazin-1-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde | C14H16N4O2 | 154816-49-6 | Details |
| Epieriocalyxin A | C20H24O5 | 191545-24-1 | Details |
| Ethynyl estradiol 3-sulfate sodium salt | C20H24O5S | 724762-79-2 | Details |
| 5-(Piperidin-4-yl)-1,2,4-oxadiazole-3-carboxamide | C8H12N4O2 | 1334147-59-9 | Details |
| AVPR1B antibody | Details |
| 3-Bromopyridine-2-carboxylic acid | C6H4BrNO2 | 30683-23-9 | Details |
| Methyl 5-bromo-1H-pyrrolo[2,3-B]pyridine-3-carboxylate | C9H7BrN2O2 | 872619-43-7 | Details |
| Salirepin | C13H18O8 | 26652-12-0 | Details |
| 2-Chloro-4-hydroxybenzoic acid monohydrate | C7H7ClO4 | 440123-65-9 | Details |
| TH 1338 | C22H21N3O4 | 1258494-60-8 | Details |
| Laurycolactone A | C18H22O5 | 85643-76-1 | Details |
| Fmoc-Phe-OH | C24H21NO4 | 35661-40-6 | Details |
| Kanamycin B | C18H37N5O10 | 4696-76-8 | Details |
| 5-Bromo-2'-deoxycytidine | C9H12BrN3O4 | 1022-79-3 | Details |
| 1,4-Diiodo-2,5-dimethylbenzene | C8H8I2 | 1124-08-9 | Details |
| (S)-Mapracorat | C25H26F4N2O2 | 887375-15-7 | Details |
| [2-(1,3-Dioxolan-2-yl)-1,3-thiazol-4-yl]methanol | C7H9NO3S | 2091750-70-6 | Details |
| rac-(3R,4S)-4-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)oxolane-3-carboxylic acid | C20H19NO5 | 2219378-56-8 | Details |
| Ac-FLEAIG-NH2 | Details |
| N2,N4-bis(4-fluorophenyl)-N6-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine | C20H16F2N8 | 1246834-49-0 | Details |
| H-Phe-D-Met-Arg-Phe-NH2 trifluoroacetate salt | C29H42N8O4S | 84313-43-9 | Details |
| Compound 1 | C20H36N2OS | Details |
| Cyanamide | CH2N2 | 420-04-2 | Details |
| (2S)-2-Amino-3-(2-methylpropoxy)propanoic acid | C7H15NO3 | 2126143-42-6 | Details |
| [(4-Methyl-2-oxo-2H-chromen-7-yl)oxy]acetic acid | C12H10O5 | 64700-15-8 | Details |
| NOVA2 Blocking Peptide | Details |
| Bis(2-(2-methoxyethoxy)ethyl)amine | C10H23NO4 | 5732-47-8 | Details |
| tert-Butyl 4,8-dioxa-1,11-diazaspiro[5.6]dodecane-11-carboxylate | C13H24N2O4 | 1251000-86-8 | Details |
| 2-(4-Chloro-1H-pyrazol-1-yl)butanoic acid | C7H9ClN2O2 | 1005629-01-5 | Details |
| 2-(4-Methoxy-3-methylphenoxy)acetic acid | C10H12O4 | 1394682-28-0 | Details |
| 2-Methyl-2-{[4-(trifluoromethoxy)phenyl]methyl}pyrrolidine hydrochloride | C13H17ClF3NO | 1955557-95-5 | Details |
| Methyl 8-oxa-5-azaspiro[3.5]nonane-7-carboxylate | C9H15NO3 | 2287332-53-8 | Details |
| BTG4 Blocking Peptide | Details |
| 1-(2-Phenylphenyl)propan-1-amine hydrochloride | C15H18ClN | 2219369-40-9 | Details |
| 8-Azidoadenosine 5'-monophosphate sodium salt | 60731-47-7 | Details |
| 4-(Aminomethyl)cubane-1-carboxylic acid hydrochloride | C10H12ClNO2 | 34132-07-5 | Details |
| NEURL Blocking Peptide | Details |
| 1-(Pyridin-4-yl)-1,4-diazepane dihydrochloride | C10H17Cl2N3 | 851292-41-6 | Details |
| 4H-?[1,?2,?4]?Triazolo[5,?1-?c]?[1,?2,?4]?benzothiadiazine 5,?5-?dioxide | C8H6N4O2S | 1311314-60-9 | Details |
| 5-Fluoro-2-(1-methyl-1H-pyrazol-5-yl)phenol | C10H9FN2O | 1547300-43-5 | Details |
| Visfatin antibody | Details |
| (4-(5-chloro-2-methylphenyl)piperazinyl)-N-benzylformamide | C19H22ClN3O | 553657-31-1 | Details |
| Methyl 3-amino-3,4-dihydro-2H-1-benzopyran-3-carboxylate hydrochloride | 1989672-39-0 | Details |
| PTBP2 Blocking Peptide | Details |
| N-(4-Chlorophenyl)-3-(hydrazinecarbonyl)benzene-1-sulfonamide | C13H12ClN3O3S | 325745-61-7 | Details |
| {2-[(4-Chlorophenyl)sulfanyl]-5-nitrophenyl}methanol | C13H10ClNO3S | 66949-31-3 | Details |
| Bicyclo[2.2.2]octane-2-sulfonyl fluoride | C8H13FO2S | 827-18-9 | Details |
| 4-Chloro-2-methyl-8-nitroquinoline | C10H7ClN2O2 | 56983-07-4 | Details |
| OR5M3 antibody | Details |
| 1-Methyl-1,2,3,4-tetrahydroquinolin-3-amine dihydrochloride | C10H16Cl2N2 | 2044836-47-5 | Details |
| H-GRTGRRNSI-OH | Details |
| ERK8 antibody | Details |
| 2-[(4-Chlorophenyl)sulfanyl]-5-methylbenzoic acid | C14H11ClO2S | 54506-81-9 | Details |
| N-Methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | C12H11N5 | 103984-27-6 | Details |
| ANA Antibody Positive Human Plasma (Speckled) | Details |
| H-AHIVMVDAYKPTK-OH | Details |
| 6,6-Dimethylspiro[3.3]heptan-2-ol | C9H16O | 2378503-51-4 | Details |
| Stresscopin-Related Peptide (free acid) (human) | Details |
| 2-[(2,6-Dimethylphenyl)imino]-1,3-thiazolidin-4-one | C11H12N2OS | 380442-86-4 | Details |
| IL1b antibody | Details |
| 7-Nitro-2,3-dihydro-1,4-benzodioxine-5-carboxylic acid | C9H7NO6 | 66410-87-5 | Details |
| 3-Hexylpiperidine hydrochloride | C11H24ClN | 956325-98-7 | Details |
| 2-Fluorophenyl chloroformate | C7H4ClFO2 | 70093-67-3 | Details |
| 6-Chlorocinnolin-4-ol | C8H5ClN2O | 876-89-1 | Details |
| 6-fluoro-1H-indazol-5-ol | C7H5FN2O | 1360884-19-0 | Details |
| 3-(Aminomethyl)-5-methylaniline dihydrochloride | C8H13ClN2 | 1909306-46-2 | Details |
| (3-Methoxyphenyl)(1-methyl-1H-imidazol-2-yl)methanamine dihydrochloride | 2031268-75-2 | Details |
| TSEN2 antibody | Details |
| Product Total： Product Page： | ||||
| 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 | ||||